Fentanyl, Dexmedetomidine

PreclinicalSmall molecule

UUniversity of Saskatchewan

Fentanyl, Dexmedetomidine is one of 17 small molecule programs targeting Amputation. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AmputationActive, not recruiting

AmputationPreclinical

Active, not recruiting

Competition

Competitive Landscape

18 competitors in Amputation

#DrugCompanyPhaseTrials

Acanya

Pfizer

Approved

1 2

Peridex

DDexcel Pharma Technologies Ltd.

Approved

1 3

Flagyl

DDePuy Orthopaedics

Approved

1 4

Ansaid

PPharmacia and Upjohn

Approved

1 5

Marcaine

IInnocoll

Preclinical

3 6

Duragesic

CCephalon

Preclinical

2 7

Prolia

OOrganon and Co

Preclinical

1 8

Oxycontin

PProtega

Preclinical

1 9

Prograf

VVeloxis Pharmaceuticals

Preclinical

1 10

Neurontin

VViatris Specialty LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Respiratory Depression1 trial

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy

Completed·UUniversity of Saskatchewan·Phase 3·NCT02987985·50 enrolled

Amputation1 trial

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

Recruiting·NNational Cancer Institute, Egypt·N/A·NCT07276867·58 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Fentanyl, Dexmedetomidine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fentanyl, Dexmedetomidine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Fentanyl, Dexmedetomidine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Saskatchewan company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Saskatchewan

Fentanyl, Dexmedetomidine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Respiratory Depression1 trial

Amputation1 trial

References

Drug Info

Quick Facts

Related News